Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model. - Wikidata - awgldk - TriplyDB

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

http://www.wikidata.org/entity/Q37207332

about

N-Heterocyclic Carbene Capture by Cytochrome P450 3A4 Membrane Fluidity Modulates Thermal Stability and Ligand Binding of Cytochrome P4503A4 in Lipid Nanodiscs.Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.The Cytochrome P450 3A4 Has Three Major Conformations: New Clues to Drug Recognition by this Promiscuous Enzyme.Spectroscopic studies of the cytochrome P450 reaction mechanisms.Inhibition of Human CYP3A4 by Rationally Designed Ritonavir-Like Compounds: Impact and Interplay of the Side Group Functionalities.7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.

P2860

Q37062535-C3B4AA39-6993-449C-8B5F-9147E41BBB19 Q37611431-61EDBC76-6CEB-46C1-AC21-FD74F973B9AF Q37627001-68E5C3FF-0F3C-406E-AEA5-49EF6638124C Q38689714-1B3BBD6D-6D8E-4AA6-AA52-75DFE78CBFF7 Q39409036-16040C66-6557-4833-9B32-B8E7E4BBB687 Q46144033-64635F5D-72F3-4354-86C7-9D14022BB6E1 Q47937263-3992FA3B-2768-4B06-91B7-71A1A03B8FE4

P2860

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

http://www.wikidata.org/entity/Q37207332

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@en

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@nl

type

label

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@en

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@nl

prefLabel

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@en

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@nl

P1433

Q37207332-92CB9B85-0853-4413-B5C2-9F4B3CC1FB0D

P1476

Q37207332-F721A9CB-CD1D-4FB0-B401-CC78BDE6979D

P2093

Q37207332-2A95F078-E371-4528-ADBC-D9AF1B4E72B5

Q37207332-2CA7C0CB-2D1B-4D4F-8FCE-8D68DCDCE97A

Q37207332-53358889-3677-47B4-BC2C-B57083E41FFE

Q37207332-D1EF65F3-9CFB-4A56-85FA-673766D65E4E

P2860

Q37207332-052446CD-45AF-496D-9D0A-5D9310453EB8

Q37207332-0A5A87B4-0ADD-4873-93FF-A95DF855059C

Q37207332-0B8A8A35-6844-4A28-9145-6C2B3CE1EB1C

Q37207332-1676018B-A32A-45CA-AD9E-ABEF733B0E6E

Q37207332-212A238B-DD37-480A-B6C7-EC99BEE04070

Q37207332-28774997-A6EA-4554-AF31-331C0B78DD9B

Q37207332-2F400174-80E4-4BE1-86B6-907622A413A2

Q37207332-3094AE2B-4EAC-46EE-B8BC-BAB70E4062A1

Q37207332-337B2F88-601A-4322-8B98-DC86878D9567

Q37207332-33F54DD4-694E-4F3F-A564-8A157285E202

P304

Q37207332-71F269DB-3760-4894-AF69-42BA4E290920

P31

Q37207332-F55E8250-3FA6-4B93-AFAA-5C56B2633C63

P356

Q37207332-FD247B84-6CF9-4C9C-9685-18735874AB20

P407

Q37207332-EB0D677D-5DE2-406A-9360-088F73992B3D

P433

Q37207332-54F3EF4C-D56D-433D-AAE7-6EF339BDD82D

P478

Q37207332-0749ED2E-264E-402D-9A05-277A66063079

P577

Q37207332-5739E160-53E0-4AF3-B7D2-89F9AE801C38

P5875

Q37207332-644B6679-2BC2-4FD0-A218-47BF48C6181C

P698

Q37207332-5BE49E8B-38BD-4224-8750-F923CEA4C0D6

P932

Q37207332-22E43BAC-DF4E-4806-BC23-7E53FF81AE00

P356

ACS.JMEDCHEM.5B01146

P1433

Journal of Medicinal Chemistry

P1476

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

@en

P2093

A Richard Chamberlin

http://www.w3.org/2001/XMLSchema#string

Irina F Sevrioukova

http://www.w3.org/2001/XMLSchema#string

Parminder Kaur

http://www.w3.org/2001/XMLSchema#string

Thomas L Poulos

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro human phase I metabolism of xenobiotics I: pesticides and related compounds used in agriculture and public health, May 2003

Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir

Pyridine-Substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 than Ritonavir

Interaction of human cytochrome P4503A4 with ritonavir analogs

Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

Features and development of Coot

The CCP4 suite: programs for protein crystallography

P304

4210-4220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JMEDCHEM.5B01146

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282036429

http://www.w3.org/2001/XMLSchema#string

P698

26371436

http://www.w3.org/2001/XMLSchema#string

P932

4998966

http://www.w3.org/2001/XMLSchema#string